5,079
Views
24
CrossRef citations to date
0
Altmetric
Perspective

A review of the current status of pericardial closure following cardiac surgery

, &
Pages 1109-1118 | Published online: 10 Jan 2014

References

  • Bittar MN, Barnard JB, Khasati N, Richardson S. Should the pericardium be closed in patients undergoing cardiac surgery? Interact. Cardiovasc. Thorac. Surg. 4(2), 151–155 (2005).
  • Morales D, Williams E, John R. Is resternotomy in cardiac surgery still a problem? Interact. Cardiovasc. Thorac. Surg. 11(3), 277–286 (2010).
  • Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation 121(7), 916–928 (2010).
  • Mookadam F, Jiamsripong P, Oh JK, Khandheria BK. Spectrum of pericardial disease: part I. Expert Rev. Cardiovasc. Ther. 7(9), 1149–1157 (2009).
  • Tyberg JV. Mechanical modulation of cardiac function: role of the pericardium. In: New Oxford Textbook of Cardiac Mechano-Electric Feedback and Arrhythmias (2nd Edition). Kohl P, Sachs F, Franz MR. Saunders, PA, USA, 281–289 (2011).
  • Gibbons-Kroeker CA, Adeeb S, Tyberg JV, Shrive NG. A 2D FE model of the heart demonstrates the role of the pericardium in ventricular deformation. Am. J. Physiol. Heart Circ. Physiol. 291(5), H2229–H2236 (2006).
  • Rao V, Komeda M, Weisel RD, Cohen G, Borger MA, David TE. Should the pericardium be closed routinely after heart operations? Ann. Thorac. Surg. 67(2), 484–488 (1999).
  • Spodick DH. The Pericardium: A Comprehensive Textbook. Marcel Dekker, NY, USA, 24–25 (1997).
  • Ninio DM, Saint DA. Passive pericardial constraint protects against stretch-induced vulnerability to atrial fibrillation in rabbits. Am. J. Physiol. Heart Circ. Physiol. 291(5), H2547–H2549 (2006).
  • Belenkie I, Dani R, Smith ER, Tyberg JV. Effects of volume loading during experimental acute pulmonary embolism. Circulation 80(1), 178–188 (1989).
  • Stone JA, Wilkes PR, Keane PM, Smith ER, Tyberg JV. Pericardial pressure attenuates release of atriopeptin in volume-expanded dogs. Am. J. Physiol. 256(3 Pt 2), H648–H654 (1989).
  • Wang SY, Sheldon RS, Bergman DW, Tyberg JV. Effects of pericardial constraint on left ventricular mechanoreceptor activity in cats. Circulation 92(11), 3331–3336 (1995).
  • Schosser R, Forst H, Racenberg J, Messmer K. Open chest and open pericardium affect the distribution of myocardial blood flow in the right ventricle. Basic Res. Cardiol. 85(5), 508–518 (1990).
  • Allard JR, Gertz EW, Verrier ED, Bristow JD, Hoffman JI. Role of the pericardium in the regulation of myocardial blood flow and its distribution in the normal and acutely failing left ventricle of the dog. Cardiovasc. Res. 17(10), 595–603 (1983).
  • Elahi M, Dhannapuneni R, Firmin R, Hickey M. Direct complications of repeat median sternotomy in adults. Asian Cardiovasc. Thorac. Ann. 13(2), 135–138 (2005).
  • Raja SG. Comment to: should the pericardium be closed in patients undergoing cardiac surgery? Interact Cardiovasc. Thorac. Surg. 4(2), 155 (2005).
  • Delius RE, Walters HL 3rd. Re-operative surgery in pediatric patients. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 6, 108–115 (2003).
  • Spodick DH. The Pericardium: A Comprehensive Textbook. Marcel Dekker, NY, USA, 387 (1997).
  • Izzat MB, Anderson M, Wilde P, Wisheart JD, Bryan AJ, Angelini GD. Hemodynamic effects and echocardiographic consequences of tension-free pericardial closure after heart valve surgery. J. Heart Valve Dis. 3(3), 295–299 (1994).
  • Sampathkumar A. Hemodynamic effects of pericardial closure. Ann. Thorac. Surg. 54(5), 1023 (1992).
  • Bahn CH, Annest LS, Miyamoto M. Pericardial closure. Am. J. Surg. 151(5), 612–615 (1986).
  • Mathisen SR, Wu HD, Sauvage LR, Walker MW. Prevention of retrosternal adhesions after pericardiotomy. J. Thorac. Cardiovasc. Surg. 92(1), 92–98 (1986).
  • Gallo I, Artiñano E, Duran CG. Late clinical results with the use of heterologous pericardium for closure of the pericardial cavity. J. Thorac. Cardiovasc. Surg. 89(5), 709–712 (1985).
  • Dobell AR, Jain AK. Catastrophic hemorrhage during redo sternotomy. Ann. Thorac. Surg. 37(4), 273–278 (1984).
  • Nandi P, Leung JS, Cheung KL. Closure of pericardium after open heart surgery. A way to prevent postoperative cardiac tamponade. Br. Heart J. 38(12), 1319–1323 (1976).
  • Asanza L, Rao G, Voleti C, Hartstein ML, Wisoff BG. Should the pericardium be closed after an open-heart operation? Ann. Thorac. Surg. 22(6), 532–534 (1976).
  • Cunningham JN Jr, Spencer FC, Zeff R, Williams CD, Cukingnan R, Mullin M. Influence of primary closure of the pericardium after open-heart surgery on the frequency of tamponade, postcardiotomy syndrome, and pulmonary complications. J. Thorac. Cardiovasc. Surg. 70(1), 119–125 (1975).
  • Roselli EE, Pettersson GB, Blackstone EH et al. Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J. Thorac. Cardiovasc. Surg. 135(2), 316–323, 323.e1 (2008).
  • Follis FM, Pett SB Jr, Miller KB, Wong RS, Temes RT, Wernly JA. Catastrophic hemorrhage on sternal reentry: still a dreaded complication? Ann. Thorac. Surg. 68(6), 2215–2219 (1999).
  • Loop FD. Catastrophic hemorrhage during sternal reentry. Ann. Thorac. Surg. 37(4), 271–272 (1984).
  • Codreanu I, Pegg TJ, Selvanayagam JB et al. Details of left ventricular remodeling and the mechanism of paradoxical ventricular septal motion after coronary artery bypass graft surgery. J. Invasive Cardiol. 23(7), 276–282 (2011).
  • Okuda H, Nakazawa M, Imai Y et al. Comparison of ventricular function after Senning and Jatene procedures for complete transposition of the great arteries. Am. J. Cardiol. 55(5), 530–534 (1985).
  • Bailey LL, Ze-jian L, Schulz E, Roost H, Yahiku P. A cause of right ventricular dysfunction after cardiac operations. J. Thorac. Cardiovasc. Surg. 87(4), 539–542 (1984).
  • Kirshbom PM, Myung RJ, Simsic JM et al. One thousand repeat sternotomies for congenital cardiac surgery: risk factors for reentry injury. Ann. Thorac. Surg. 88(1), 158–161 (2009).
  • Morales DL, Zafar F, Arrington KA et al. Repeat sternotomy in congenital heart surgery: no longer a risk factor. Ann. Thorac. Surg. 86(3), 897–902; discussion 897 (2008).
  • Lahtinen J, Satta J, Lähde S et al. Computed tomographic evaluation of retrosternal adhesions after pericardial substitution. Ann. Thorac. Surg. 66(4), 1264–1268 (1998).
  • Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann. Thorac. Surg. 88(1), 326–333 (2009).
  • Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur. Heart J. 27(2), 136–149 (2006).
  • Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J. Surg. Res. 135(1), 68–75 (2006).
  • Kroeker CA, Shrive NG, Belenkie I, Tyberg JV. Pericardium modulates left and right ventricular stroke volumes to compensate for sudden changes in atrial volume. Am. J. Physiol. Heart Circ. Physiol. 284(6), H2247–H2254 (2003).
  • Esch BT, Scott JM, Haykowsky MJ, McKenzie DC, Warburton DE. Diastolic ventricular interactions in endurance-trained athletes during orthostatic stress. Am. J. Physiol. Heart Circ. Physiol. 293(1), H409–H415 (2007).
  • Spodick DH. Intrapericardial therapy and diagnosis. Curr. Cardiol. Rep. 4(1), 22–25 (2002).
  • Cui HB, Chen XY, Cui CC et al. Prevention of pericardial constriction by transcatheter intrapericardial fibrinolysis with urokinase. Chin. Med. Sci. J. 20(1), 5–10 (2005).
  • Frasiolas JA, Cahoon WD. Intrapericardial triamcinolone administration for autoreactive pericarditis. Ann. Pharmacother. 44(10), 1641–1646 (2010).
  • Kunitoh H, Tamura T, Shibata T et al. .; JCOG Lung Cancer Study Group, Tokyo, Japan. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br. J. Cancer 100(3), 464–469 (2009).
  • Maisch B, Ristic AD, Seferovic PM, Spodick DH. Intrapericardial treatment of autoreactive myocarditis with triamcinolon. Successful administration in patients with minimal pericardial effusion. Herz 25(8), 781–786 (2000).
  • Maxwell CB, Crouch MA. Intrapericardial triamcinolone for acute pericarditis after electrophysiologic procedures. Am. J. Health. Syst. Pharm. 67(4), 269–273 (2010).
  • Oida T, Mimatsu K, Kano H et al. Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J. Gastroenterol. 16(6), 740–744 (2010).
  • Reuter H, Burgess LJ, Louw VJ, Doubell AF. Experience with adjunctive corticosteroids in managing tuberculous pericarditis. Cardiovasc. J. S. Afr. 17(5), 233–238 (2006).
  • Smiseth OA, Frais MA, Kingma I, Smith ER, Tyberg JV. Assessment of pericardial constraint in dogs. Circulation 71(1), 158–164 (1985).
  • Gibbon’s Surgery of the Chest. Sabiston DC, Spencer FC (Eds). WB Saunders Company, PA, USA (1969).
  • Boyd WD, Johnson WE 3rd, Sultan PK, Deering TF, Matheny RG. Pericardial reconstruction using an extracellular matrix implant correlates with reduced risk of postoperative atrial fibrillation in coronary artery bypass surgery patients. Heart Surg. Forum 13(5), E311–E316 (2010).
  • Kargar F, Aazami MH. Rotational pericardial flap: an alternative tension-free technique for pericardial closure. J. Thorac. Cardiovasc. Surg. 134(2), 510–511 (2007).
  • Ghorpade N, Hill D, Mohajeri M. Alternative for primary pericardial closure: sentry for re-entry. Heart Lung Circ. 13(1), 52–55 (2004).
  • Bhatnagar G, Fremes SE, Christakis GT, Goldman BS. Early results using an ePTFE membrane for pericardial closure following coronary bypass grafting. J. Card. Surg. 13(3), 190–193 (1998).
  • Berry WR, Klingman RR, Ferraris VA. Pericardial closure without pericardial substitute. Ann. Thorac. Surg. 55(6), 1580–1581 (1993).
  • Daughters GT, Frist WH, Alderman EL, Derby GC, Ingels NB Jr, Miller DC. Effects of the pericardium on left ventricular diastolic filling and systolic performance early after cardiac operations. J. Thorac. Cardiovasc. Surg. 104(4), 1084–1091 (1992).
  • Hunter S, Smith GH, Angelini GD. Adverse hemodynamic effects of pericardial closure soon after open heart operation. Ann. Thorac. Surg. 53(3), 425–429 (1992).
  • Damen J, Bolton DT. Acute hemodynamic effects of pericardial closure in man. Acta Anaesthesiol. Scand. 33(3), 207–209 (1989).
  • Järvinen A, Peltola K, Räsänen J, Heikkilä J. Immediate hemodynamic effects of pericardial closure after open-heart surgery. Scand. J. Thorac. Cardiovasc. Surg. 21(2), 131–134 (1987).
  • Li JY, Chen YS, Wu SJ, Hu PY. Modified pericardial closure to protect internal mammary artery grafts in coronary artery bypass. Thorac. Cardiovasc. Surg. 50(3), 182–183 (2002).
  • Zapolanski A, Fishman NH, Bronstein MN, Ellertson DG, O’Connell TJ, Siegel S. Modified pericardial closure to protect cardiovascular structures during sternal reentry. Ann. Thorac. Surg. 50(4), 665–666 (1990).
  • Bahn CH. Pericardial closure. J. Thorac. Cardiovasc. Surg. 93(2), 317–318 (1987).
  • Matsumura G, Shin’oka T, Ikada Y, Sakamoto T, Kurosawa H. Novel anti-adhesive pericardial substitute for multistage cardiac surgery. Asian Cardiovasc. Thorac. Ann. 16(4), 309–312 (2008).
  • Merav AD, Brodman R, Attai LA, Robinson G. A simple technique for tension-free pericardial closure. Ann. Thorac. Surg. 28(4), 399–400 (1979).
  • Milgalter E, Uretzky G, Siberman S et al. Pericardial meshing: an effective method for prevention of pericardial adhesions and epicardial reaction after cardiac operations. J. Thorac. Cardiovasc. Surg. 90(2), 281–286 (1985).
  • Kageyama Y, Suzuki K, Matsushita K, Nogimura H, Kazui T. Pericardial closure using fascia lata in patients undergoing pneumonectomy with pericardiectomy. Ann. Thorac. Surg. 66(2), 586–587 (1998).
  • Kohanna FH, Adams PX, Cunningham JN Jr, Spencer FC. Use of autologous fascia lata as a pericardial substitute following open-heart surgery. J. Thorac. Cardiovasc. Surg. 74(1), 14–19 (1977).
  • Tamesue K, Hara K, Hara F, Nakajima T. Pericardial reconstruction using a pedicle flap of the diaphragmatic central tendon. Jpn J. Thorac. Cardiovasc. Surg. 53(9), 494–497 (2005).
  • Biancari F, Mahar MA. Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 139(5), 1158–1161 (2010).
  • Yorgancioglu C, Farsak B, Tokmakoglu H, Günaydin S. An unusual experience with posterior pericardiotomy. Eur. J. Cardiothorac. Surg. 18(6), 727–728 (2000).
  • Bunton RW, Xabregas AA, Miller AP. Pericardial closure after cardiac operations. An animal study to assess currently available materials with particular reference to their suitability for use after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 100(1), 99–107 (1990).
  • Amato JJ, Cotroneo JV, Galdieri RJ, Alboliras E, Antillon J, Vogel RL. Experience with the polytetrafluoroethylene surgical membrane for pericardial closure in operations for congenital cardiac defects. J. Thorac. Cardiovasc. Surg. 97(6), 929–934 (1989).
  • Jacobs JP, Iyer RS, Weston JS et al. Expanded PTFE membrane to prevent cardiac injury during resternotomy for congenital heart disease. Ann. Thorac. Surg. 62(6), 1778–1782 (1996).
  • Lahtinen J, Satta J, Pokela R, Nissinen J, Juvonen T. Pericardial closure with polytetrafluoroethylene surgical membrane or biodegradable polyglycolic acid mesh after coronary artery bypass surgery – a baseline report. Ann. Chir. Gynaecol. 87(1), 36–39 (1998).
  • Loebe M, Alexi-Meskhishvili V, Weng Y, Hausdorf G, Hetzer R. Use of polytetrafluoroethylene surgical membrane as a pericardial substitute in the correction of congenital heart defects. Tex. Heart Inst. J. 20(3), 213–217 (1993).
  • Minale C, Hollweg G, Nikol S, Mittermayer C, Messmer BJ. Closure of the pericardium using expanded polytetrafluoroethylene GORE-TEX-Surgical Membrane: clinical experience. Thorac. Cardiovasc. Surg. 35(5), 312–315 (1987).
  • Vitali E, Russo C, Tiziano C, Lanfranconi M, Bruschi G. Modified pericardial closure technique in patients with ventricular-assist device. Ann. Thorac. Surg. 69(4), 1278–1279 (2000).
  • Holman WL, Pamboukian SV, Bellot SC et al. Use of an intraperitoneal ventricular-assist device with a polytetrafluoroethylene barrier decreases infections. J. Heart Lung Transplant. 27(3), 268–271 (2008).
  • Leprince P, Rahmati M, Bonnet N et al. Expanded polytetrafluoroethylene membranes to wrap surfaces of circulatory support devices in patients undergoing bridge to heart transplantation. Eur. J. Cardiothorac. Surg. 19(3), 302–306 (2001).
  • Ozeren M, Han U, Mavioglu I et al. Consequences of PTFE membrane used for prevention of re-entry injuries in rheumatic valve disease. Cardiovasc. Surg. 10(5), 489–493 (2002).
  • Sakuma K, Iguchi A, Ikada Y, Tabayashi K. Closure of the pericardium using synthetic bioabsorbable polymers. Ann. Thorac. Surg. 80(5), 1835–1840 (2005).
  • Gabbay S, Bortolotti U, Factor S, Shore DF, Frater RW. Calcification of implanted xenograft pericardium. Influence of site and function. J. Thorac. Cardiovasc. Surg. 87(5), 782–787 (1984).
  • Meus PJ, Wernly JA, Campbell CD et al. Long-term evaluation of pericardial substitutes. J. Thorac. Cardiovasc. Surg. 85(1), 54–58 (1983).
  • Allan A, Turner MA. Pericardial closure with pericardial xenograft. J. Thorac. Cardiovasc. Surg. 93(6), 942 (1987).
  • Eng J, Ravichandran PS, Abbott CR, Kay PH, Murday AJ, Shreiti I. Reoperation after pericardial closure with bovine pericardium. Ann. Thorac. Surg. 48(6), 813–815 (1989).
  • Gabbay S, Guindy AM, Andrews JF, Amato JJ, Seaver P, Khan MY. New outlook on pericardial substitution after open heart operations. Ann. Thorac. Surg. 48(6), 803–812 (1989).
  • Mills SA. Complications associated with the use of heterologous bovine pericardium for pericardial closure. J. Thorac. Cardiovasc. Surg. 92(3 Pt 1), 446–449 (1986).
  • Skinner JR, Kim H, Toon RS, Kongtahworn C, Phillips SJ, Zeff RH. Inflammatory epicardial reaction to processed bovine pericardium: case report. J. Thorac. Cardiovasc. Surg. 88(5 Pt 1), 789–791 (1984).
  • Duvernoy O, Malm T, Ramström J, Bowald S. A biodegradable patch used as a pericardial substitute after cardiac surgery: 6- and 24-month evaluation with CT. Thorac. Cardiovasc. Surg. 43(5), 271–274 (1995).
  • Lodge AJ, Wells WJ, Backer CL et al.. A novel bioresorbable film reduces postoperative adhesions after infant cardiac surgery. Ann. Thorac. Surg. 86(2), 614–621 (2008).
  • Walther T, Rastan A, Dähnert I et al. A novel adhesion barrier facilitates reoperations in complex congenital cardiac surgery. J. Thorac. Cardiovasc. Surg. 129(2), 359–363 (2005).
  • Duncan DA, Yaacobi Y, Goldberg EP et al. Prevention of postoperative pericardial adhesions with hydrophilic polymer solutions. J. Surg. Res. 45(1), 44–49 (1988).
  • Krause TJ, Zazanis G, Malatesta P, Solina A. Prevention of pericardial adhesions with N–O carboxymethylchitosan in the rabbit model. J. Invest. Surg. 14(2), 93–97 (2001).
  • Malm T, Bowald S, Bylock A, Saldeen T, Busch C. Regeneration of pericardial tissue on absorbable polymer patches implanted into the pericardial sac. An immunohistochemical, ultrastructural and biochemical study in the sheep. Scand. J. Thorac. Cardiovasc. Surg. 26(1), 15–21 (1992).
  • Mitchell JD, Lee R, Neya K, Vlahakes GJ. Reduction in experimental pericardial adhesions using a hyaluronic acid bioabsorbable membrane. Eur. J. Cardiothorac. Surg. 8(3), 149–152 (1994).
  • Mitchell JD, Lee R, Hodakowski GT et al. Prevention of postoperative pericardial adhesions with a hyaluronic acid coating solution. Experimental safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 107(6), 1481–1488 (1994).
  • Nkere UU, Whawell SA, Sarraf CE, Schofield JB, O’Keefe PA. Pericardial substitution after cardiopulmonary bypass surgery: a trial of an absorbable patch. Thorac. Cardiovasc. Surg. 46(2), 77–83 (1998).
  • Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 5(1), 1–13 (2009).
  • Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin. Immunol. 20(2), 109–116 (2008).
  • Badylak S, Obermiller J, Geddes L, Matheny R. Extracellular matrix for myocardial repair. Heart Surg. Forum 6(2), E20–E26 (2003).
  • Robinson KA, Li J, Mathison M et al. Extracellular matrix scaffold for cardiac repair. Circulation 112(Suppl. 9), I135–I143 (2005).
  • Beattie AJ, Gilbert TW, Guyot JP, Yates AJ, Badylak SF. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng. Part A 15(5), 1119–1125 (2009).
  • Matheny RG, Hutchison ML, Dryden PE, Hiles MD, Shaar CJ. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J. Heart Valve Dis. 9(6), 769–774; discussion 774 (2000).
  • Zhao ZQ, Puskas JD, Xu D et al. Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. J. Am. Coll. Cardiol. 55(12), 1250–1261 (2010).
  • Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur. J. Cardiovasc. Prev. Rehabil. 15(6), 735–741 (2008).
  • Spodick DH. The Pericardium: A Comprehensive Textbook. Marcel Dekker, NY, USA, 16–17 (1997).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.